Skip to content
Tenfell
Awarded contract
Published 15 Jun 2020

Appointment of Contract Development and Manufacturing Organization (CDMO) for Vaccine Production

Public Health England · United Kingdom

Key facts

Contract value
£1,250,000
Awarded
30 Dec 2019
Contract starts
14 Jan 2020
Contract ends
31 Mar 2021
Procedure
Negotiated procedure without prior publication (above threshold)
Buyer type
Central government

Awarded to

SupplierValue
ABL Europe SAS£1,250,000

Description

Public Health England (PHE) has awarded a contract to ABL Europe SAS to provide comprehensive services supporting vaccine development through its manufacturing. The project required establishing manufacturing conditions based on existing knowledge of Modified Vaccinia Ankara (MVA) viral vector production and quality control (QC) testing, to support Good Manufacturing Practice (GMP) release of drug product by end of Q1 / early Q2 2021.

The contract was awarded following extensive market research and publication of Voluntary Ex ante Transparency Notice (VEAT) notice in Official Journal of European Union (OJEU) - reference # 2019-042862 (document number 2019/S 245-603016).

The contract is until 31.03.21 with an option of 2 extensions of 12 months each.

Categories (CPV)

Similar open tenders

About Public Health England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.